Analysis: Bafna Pharmaceuticals Limited

NSE:BAFNAPH Pharma - Formulators Market cap: ₹714 cr

Research report

companyname: BAFNA PHARMACEUTICALS LIMITED ticker: BAFNAPH sector: Pharmaceuticals Bafna Pharmaceuticals Limited is a 31-year-old, NSE and BSE-listed pharmaceutical company that develops, manufactures, and exports finished pharmaceutical formulations. The company started as an institutional supplier and has transformed into a generic drug manufacturer and contract research and manufacturing services (CRAMS) partner. It operates from a single manufacturing facility in Grantlyon, Chennai, after h...

Read the full report →
RS rating: 97 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Bafna Pharmaceuticals Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.